Involvement of sodium-glucose cotransporter-1 activities in maintaining oscillatory Cl currents from mouse submandibular acinar cells.

J Comp Physiol B

Department of Physiology and Oral Physiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, 734-8553, Japan.

Published: February 2024

In salivary acinar cells, cholinergic stimulation induces elevations of cytosolic [Ca] to activate the apical exit of Cl through TMEM16A Cl channels, which acts as a driving force for fluid secretion. To sustain the Cl secretion, [Cl] must be maintained to levels that are greater than the electrochemical equilibrium mainly by Na-K-2Cl cotransporter-mediated Cl entry in basolateral membrane. Glucose transporters carry glucose into the cytoplasm, enabling the cells to produce ATP to maintain Cl and fluid secretion. Sodium-glucose cotransporter-1 is a glucose transporter highly expressed in acinar cells. The salivary flow is suppressed by the sodium-glucose cotransporter-1 inhibitor phlorizin. However, it remains elusive how sodium-glucose cotransporter-1 contributes to maintaining salivary fluid secretion. To examine if sodium-glucose cotransporter-1 activity is required for sustaining Cl secretion to drive fluid secretion, we analyzed the Cl currents activated by the cholinergic agonist, carbachol, in submandibular acinar cells while comparing the effect of phlorizin on the currents between the whole-cell patch and the gramicidin-perforated patch configurations. Phlorizin suppressed carbachol-induced oscillatory Cl currents by reducing the Cl efflux dependent on the Na-K-2Cl cotransporter-mediated Cl entry in addition to affecting TMEM16A activity. Our results suggest that the sodium-glucose cotransporter-1 activity is necessary for maintaining the oscillatory Cl secretion supported by the Na-K-2Cl cotransporter activity in real time to drive fluid secretion. The concerted effort of sodium-glucose cotransporter-1, Na-K-2Cl cotransporter, and apically located Cl channels might underlie the efficient driving of Cl secretion in different secretory epithelia from a variety of animal species.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940492PMC
http://dx.doi.org/10.1007/s00360-024-01532-wDOI Listing

Publication Analysis

Top Keywords

sodium-glucose cotransporter-1
28
fluid secretion
20
acinar cells
16
secretion
9
maintaining oscillatory
8
oscillatory currents
8
submandibular acinar
8
cells salivary
8
na-k-2cl cotransporter-mediated
8
cotransporter-mediated entry
8

Similar Publications

SGLT2 inhibitors (SGLT2i) and GLP1 receptor (GLP1R) agonists have kidney protective effects. To better understand their molecular effects, RNA sequencing was performed in SGLT2-positive proximal tubule segments isolated by immunostaining-guided laser capture microdissection. Male adult DBA wild-type (WT) and littermate diabetic Akita mice ± knockout (-KO) were given vehicle or SGLT2i dapagliflozin (dapa; 10 mg/kg diet) for 2 wk, and other Akita mice received GLP1R agonist semaglutide [sema; 3 nmol/(kg body wt·day), sc].

View Article and Find Full Text PDF

The sweet taste of saccharides, such as sucrose and glucose, and other sweeteners is known to result from activation of the TAS1R2/R3 receptor expressed in taste receptor cells (TRCs) of the taste bud. Recent reports have suggested the existence of an additional sweet taste signaling pathway for metabolizable saccharides that is dependent on the activity of glucose transporters, especially SGLT1, also expressed in TRCs. We have investigated the potential contribution of SGLT1 to glucose taste signaling in humans.

View Article and Find Full Text PDF

Uninephrectomy and sodium-glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia.

Physiol Rep

November 2024

Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

The kidneys are essential for glucose homeostasis, as they perform gluconeogenesis, utilize glucose, and reabsorb glucose. Reabsorption is performed by SGLT2, which is responsible for about 90%. However, little is known about how renal glucose handling is altered in patients with chronic kidney disease (CKD).

View Article and Find Full Text PDF

Synthesis of a Small Library of Glycoderivative Putative Ligands of SGLT1 and Preliminary Biological Evaluation.

Molecules

October 2024

Department of Earth and Environmental Sciences DISAT, Università degli Studi di Milano-Bicocca, Piazza della Scienza 1, 20126 Milan, Italy.

Sodium-glucose co-transporter 1 (SGLT1) is primarily expressed on the membrane of enterocytes, a type of epithelial cell found in the intestines, where it mediates the unidirectional absorption of glucose and galactose. Beyond its well-established role in nutrient absorption, SGLT1 also plays a protective role in maintaining the integrity of the intestinal barrier. Specifically, the natural ligand of SGLT1 (d-glucose) and a synthetic -glucoside developed by our group can induce a protective anti-inflammatory effect on the intestinal epithelium.

View Article and Find Full Text PDF

The Impact of SGLT1 Inhibition on Frailty and Sarcopenia: A Mediation Mendelian Randomization Study.

J Cachexia Sarcopenia Muscle

December 2024

Department of Geriatrics, First Affiliated Hospital of Fujian Medical University, Institute of Neuroscience, Fujian Medical University, Fuzhou, China.

Article Synopsis
  • The study explored the effect of inhibiting SGLT1 on frailty and sarcopenia in older adults, aiming to understand its potential benefits.
  • A two-sample Mendelian randomization analysis showed that SGLT1 inhibition led to a decrease in frailty index and a lower risk of weak grip strength in individuals aged 60 and over.
  • Findings identified insulin resistance and various proteins and metabolites as mediators, suggesting that targeting SGLT1 could be a promising therapeutic approach for improving health in older adults.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!